Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer

Postoperative non-small cell lung cancer (NSCLC) patients require adjuvant therapy to improve their prognosis. In this study, we investigated the efficacy of a sequential combination of autologous cellular immunotherapy (CIT) and chemotherapy for postoperative NSCLC. This retrospective study include...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncoimmunology
Main Authors: Pan, Qiu-Zhong, Tang, Yan, Wang, Qi-Jing, Li, Yong-Qiang, Zhang, Li, Li, Xiao-Dong, Zhao, Jing-Jing, Weng, De-Sheng, Liu, Qing, Huang, Li-Xi, He, Jia, Chen, Shi-Ping, Ke, Miao-La, Zeng, Yi-Xin, Xia, Jian-Chuan
Format: Artigo
Jezik:Inglês
Izdano: Taylor & Francis 2015
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4570139/
https://ncbi.nlm.nih.gov/pubmed/26405607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1038017
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki